214 related articles for article (PubMed ID: 16750176)
1. Attenuation of osteoclastogenesis and osteoclast function by apigenin.
Bandyopadhyay S; Lion JM; Mentaverri R; Ricupero DA; Kamel S; Romero JR; Chattopadhyay N
Biochem Pharmacol; 2006 Jul; 72(2):184-97. PubMed ID: 16750176
[TBL] [Abstract][Full Text] [Related]
2. Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells.
Pang JL; Ricupero DA; Huang S; Fatma N; Singh DP; Romero JR; Chattopadhyay N
Biochem Pharmacol; 2006 Mar; 71(6):818-26. PubMed ID: 16434028
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
4. 8,8''-Biapigeninyl stimulates osteoblast functions and inhibits osteoclast and adipocyte functions: Osteoprotective action of 8,8''-biapigeninyl in ovariectomized mice.
Siddiqui JA; Swarnkar G; Sharan K; Chakravarti B; Sharma G; Rawat P; Kumar M; Khan FM; Pierroz D; Maurya R; Chattopadhyay N
Mol Cell Endocrinol; 2010 Jul; 323(2):256-67. PubMed ID: 20380869
[TBL] [Abstract][Full Text] [Related]
5. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha).
Woo JT; Nakagawa H; Krecic AM; Nagai K; Hamilton AD; Sebti SM; Stern PH
Biochem Pharmacol; 2005 Jan; 69(1):87-95. PubMed ID: 15588717
[TBL] [Abstract][Full Text] [Related]
8. Osteoclastogenesis is decreased by cysteine proteinase inhibitors.
Brage M; Lie A; Ransjö M; Kasprzykowski F; Kasprzykowska R; Abrahamson M; Grubb A; Lerner UH
Bone; 2004 Mar; 34(3):412-24. PubMed ID: 15003789
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling.
Yamashita M; Otsuka F; Mukai T; Yamanaka R; Otani H; Matsumoto Y; Nakamura E; Takano M; Sada KE; Makino H
Regul Pept; 2010 Jun; 162(1-3):99-108. PubMed ID: 20346376
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
[TBL] [Abstract][Full Text] [Related]
11. Regulation of osteoclastogenesis by gap junction communication.
Matemba SF; Lie A; Ransjö M
J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710
[TBL] [Abstract][Full Text] [Related]
12. Effect of cytosolic phospholipase A2 on proinflammatory cytokine-induced bone resorptive genes including receptor activator of nuclear factor kappa B ligand in human dental pulp cells.
Kim YS; Min KS; Lee HD; Oh HW; Kim EC
J Endod; 2010 Apr; 36(4):636-41. PubMed ID: 20307736
[TBL] [Abstract][Full Text] [Related]
13. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
Kanatani M; Sugimoto T; Kaji H; Kobayashi T; Nishiyama K; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1995 Nov; 10(11):1681-90. PubMed ID: 8592944
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
van't Hof RJ; Ralston SH
J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
[TBL] [Abstract][Full Text] [Related]
15. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.
Axmann R; Böhm C; Krönke G; Zwerina J; Smolen J; Schett G
Arthritis Rheum; 2009 Sep; 60(9):2747-56. PubMed ID: 19714627
[TBL] [Abstract][Full Text] [Related]
17. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation.
de Vries TJ; Schoenmaker T; Beertsen W; van der Neut R; Everts V
J Cell Biochem; 2005 Apr; 94(5):954-66. PubMed ID: 15578568
[TBL] [Abstract][Full Text] [Related]
18. TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.
Yen ML; Tsai HF; Wu YY; Hwa HL; Lee BH; Hsu PN
Mol Immunol; 2008 Apr; 45(8):2205-13. PubMed ID: 18206242
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4.
Chang EJ; Kim HJ; Ha J; Kim HJ; Ryu J; Park KH; Kim UH; Lee ZH; Kim HM; Fisher DE; Kim HH
J Cell Sci; 2007 Jan; 120(Pt 1):166-76. PubMed ID: 17164294
[TBL] [Abstract][Full Text] [Related]
20. IL-4, but not vitamin D(3), induces monoblastic cell line UG3 to differentiate into multinucleated giant cells on osteoclast lineage.
Kaji Y; Ikeda K; Ikeda T; Kawakami K; Sasaki K; Shindo M; Hatake K; Harada M; Motoyoshi K; Mori S; Norimatsu H; Takahara J
J Cell Physiol; 2000 Feb; 182(2):214-21. PubMed ID: 10623885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]